Monster TB - Search Results

1

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.

van Vlijmen EF, Wiewel-Verschueren S, Monster TB, Meijer K. van Vlijmen EF, et al. Among authors: monster tb. J Thromb Haemost. 2016 Jul;14(7):1393-403. doi: 10.1111/jth.13349. Epub 2016 Jun 16. J Thromb Haemost. 2016. PMID: 27121914 Free article. Review.

2

Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.

Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT; Prevention of Renal and Vascular End Stage Disease Study Group. Monster TB, et al. Arch Intern Med. 2001 Sep 10;161(16):2000-5. doi: 10.1001/archinte.161.16.2000. Arch Intern Med. 2001. PMID: 11525702

3

The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.

Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT; PREVEND Study Group. Monster TB, et al. Br J Clin Pharmacol. 2002 Jan;53(1):31-6. doi: 10.1046/j.0306-5251.2001.01503.x. Br J Clin Pharmacol. 2002. PMID: 11849192 Free PMC article.

4

Corticosteroid use and its association with microalbuminuria in the adult population.

Monster TB, Janssen WM, de Jong PE, de Jong-van de Berg LT. Monster TB, et al. Pulm Pharmacol Ther. 2003;16(6):349-53. doi: 10.1016/S1094-5539(03)00104-4. Pulm Pharmacol Ther. 2003. PMID: 14580926

5

Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.

Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT; PREVEND Study Group Prevention of REnal and Vascular ENT Stage Disease. Monster TB, et al. Pharmacoepidemiol Drug Saf. 2002 Jul-Aug;11(5):379-84. doi: 10.1002/pds.722. Pharmacoepidemiol Drug Saf. 2002. PMID: 12271879

6

Drug-induced renal function impairment: a population-based survey.

Monster TB, de Jong PE, de Jong-van den Berg LT. Monster TB, et al. Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):135-43. doi: 10.1002/pds.811. Pharmacoepidemiol Drug Saf. 2003. PMID: 12642977

7

The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs.

Atthobari J, Monster TB, de Jong PE, de Jong-van den Berg LT; Prevend Study Group. Atthobari J, et al. Among authors: monster tb. Br J Clin Pharmacol. 2004 Mar;57(3):328-36. doi: 10.1046/j.1365-2125.2003.02011.x. Br J Clin Pharmacol. 2004. PMID: 14998429 Free PMC article. Clinical Trial.

8

Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?

Rijcken CA, Monster TB, Brouwers JR, de Jong-van den Berg LT. Rijcken CA, et al. Among authors: monster tb. J Clin Psychopharmacol. 2003 Dec;23(6):657-9. doi: 10.1097/01.jcp.0000096247.29231.3a. J Clin Psychopharmacol. 2003. PMID: 14624195

9

How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information.

Schirm E, Monster TB, de Vries R, van den Berg PB, de Jong-van den Berg LT, Tobi H. Schirm E, et al. Among authors: monster tb. Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):173-9. doi: 10.1002/pds.882. Pharmacoepidemiol Drug Saf. 2004. PMID: 15072117

10

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.

Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sørensen HT. Monster TB, et al. Am J Med. 2004 Nov 15;117(10):732-7. doi: 10.1016/j.amjmed.2004.06.027. Am J Med. 2004. PMID: 15541322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page